NEVVI Medicare utilization intelligence
+ Build a code basket
Market snapshot

Nationwide CY2024

Medicare Part B FFS · CY2024 · as published by CMS
84560 Uric acid level CPT · General Laboratory test
Classification Test General Laboratory Clinical Chemistry (CMS RBCS)
First observed 2013 — start of our 12-year window; the code predates it
National scale 141,043 services · est. ▲ 4.8% YoY · 57,183 FFS beneficiaries (CY2024, all-Medicare estimate) — 70,348 observed fee-for-service services
Medicare paid $702K · est. · $4.98 avg / service, national — $350K observed FFS
CMS descriptor · RBCS classification · Medicare Part B physician/supplier claims, 12-year window
Billing groups

3

Named groups billing this code
Named-group all-Medicare svcs · est.

327

Scaled from 163 observed FFS services.
FFS of Medicare

49%

Payer-mix frame
Services · year over year
Services YoY

+4.8%

All-Medicare est. · observed FFS +1.2%
Volume, not care. A shrinking fee-for-service denominator is not a shrinking market.
Estimated all-Medicare volume estimate
FFS + estimated MA

~327 services

163 observed fee-for-service (50%) · ~164 estimated Medicare Advantage.

Billing for this code concentrates in one state — scaled by the national payer mix (FFS share as of 2024) — scaled estimate — assumes MA utilization mirrors FFS; not an observation. How we scale
Top states — 84560 (CY2024)

Est. all-Medicare services by billing state (scaled estimate — assumes MA utilization mirrors FFS); open a bar for that state's ranked market.

Billed → allowed → paid
Named-group submitted charges
$4K
Named-group allowed amount
$802
Named-group Medicare payments
$2K · est.
— $802 observed FFS
Avg charge / svc
$23
Avg allowed / svc
$5
Avg payment / svc
$5
Totals are named-group (attributable) sums. Allowed is Medicare’s fee-schedule recognized price — what CMS recognizes, before the 80% Medicare pays.
Average charge per group
$18 3 groups · avg submitted charge / service $25
Market analyticsPlatform Methods →

Search a single state to see that market's full analytics — each panel renders gated on the free tier.

See it in full: nuclear heart imaging (78452) in Arizona is open as a live example — every paid panel, on real data.

View the live example →
See the Platform — the full read, every number below, code baskets, and export. Notify me at launch →
Refine: group size any 5+ locked column25+ locked column100+ locked column independent only locked column
Filter results:

Email me this CSV

Data year: CY2024 CY2023 CY2022 locked column CY2021 locked column CY2020 locked column
Physician groups ranked by 84560 services, highest first, CY2024
# Physician group locked column City locked column St locked column Specialty locked column Providers locked column 84560 svcs Submitted charges locked column Avg charge locked column Medicare $ locked column Share of state* locked column Phone
1 MINNESOTA UROLOGY, PA WOODBURY MN PHYSICIAN ASSISTANT 81 112 $2,800 $25 premium 9.3% (651) 999-6800
2 MICHIGAN INSTITUTE OF UROLOGY PC SAINT CLAIR SHORES MI UROLOGY 84 36 $648 $18 premium 45.6% (586) 771-4820
3 CLEVELAND CLINIC CLEVELAND OH PHYSICIAN ASSISTANT 6828 15 $345 $23 premium 8.7%

*Share of the state's disclosed Medicare-FFS services for the primary code, counted once per clinician. "St" is the state the volume was billed from: a group appears in each state where its clinicians bill Medicare, with that state's volume and share ("City" is the group's registered location). Group figures sum clinicians affiliated with exactly one group; clinicians in several groups are listed in each group's drill-down but not volume-attributed to any single group, so shares reflect attributable volume. See Methods.

Comparing against an all-payer estimate?

These are exact counts from Medicare fee-for-service claims — roughly a third to half of most procedure markets, depending on payer mix — and the observed foundation every market figure here builds on. Market totals anchor on a labeled all-Medicare estimate scaled from that foundation, with the observed count disclosed beside it — Medicare only, never all-payer. Modeled all-payer databases project every payer statistically and typically run higher. Same market, different denominator. How the numbers reconcile →